Search results
Clinical trial: New drug makes exercise, everyday tasks easier for people with common heart...
Medical Xpress· 5 hours agoPeople with a common heart condition were able to use significantly more oxygen while exercising...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials By Investing.com
Investing.com· 7 hours agoVaxart, Inc. (NASDAQ: NASDAQ:VXRT), a biotechnology company specializing in the development of oral...
Cardurion’s PDE9 inhibitor increases cGMP in Phase IIa heart failure trial
Clinical Trials Arena via Yahoo Finance· 20 hours agoCardurion Pharmaceuticals has said its phosphodiesterase-9 (PDE9) inhibitor, CRD-740, has met the...
Replicate Bioscience Presents Positive Data from Phase 1 Trial and Preclinical Data with Novel...
KOIN News 6 Portland· 3 days ago"At ASGCT, Replicate is presenting two important breakthroughs in srRNA...
Clinical trial investigating aficamten meets primary endpoint in obstructive hypertrophic...
Medical Xpress· 10 hours agoEven though mortality and hospitalization rates have improved, the quality of life for those living...
Merck stopped a clinical trial for its experimental skin cancer drug after a high rate of side...
Quartz· 13 hours agoMerck announced Monday that it is pulling the plug on its phase 3 trial of an experimental...
Gene Editing Breakthrough: CRISPR Improves Vision in Clinical Trial
SciTechDaily· 10 hours agoMass Eye and Ear researchers say their findings support continued research and clinical trials of...
...to-head Superiority to High-dose Dulaglutide: Innovent's First Phase 3 Clinical Trial of...
Char-Koosta News· 5 days ago(Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and...
Analyst Report: Fortrea Holdings Inc.
Morningstar Research via Yahoo Finance· 7 hours agoFortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial
Earnings call: Imunon reports on Q1 2024, optimistic about cancer treatment
Investing.com· 1 day agoImunon (ticker: IMNN) has announced its financial results and progress in clinical trials for the...
